Retrocyclin-112, RC-112

General Information


DRACP ID  DRACP03465

Peptide Name   Retrocyclin-112, RC-112

Sequence  GicrcicGrGicrcicGr

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C8H-14N4O-9

Absent amino acids  ACDEFHIKLMNPQRSTVWY

Common amino acids  G

Mass  29740

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  376

Hydrophobicity  -8.89

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16790431

Title  Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin

Doi Not available

Year  2006

Literature 2

Pubmed ID 15175019

Title  A theta-defensin composed exclusively of D-amino acids is active against HIV-1

Doi Not available

Year  2004

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  3808

DRACP is developed by Dr.Zheng's team.